Nuveen Floating Rate Income Fund (JFR) At $10.83 Forms Bottom; Cardiovascular Systems (CSII) Sentiment Is 1.02

Nuveen Floating Rate Income Fund (JFR) formed multiple bottom with $10.40 target or 4.00% below today’s $10.83 share price. Nuveen Floating Rate Income Fund (JFR) has $616.43 million valuation. The stock increased 0.19% or $0.02 during the last trading session, reaching $10.83. About 145,281 shares traded. Nuveen Floating Rate Income Fund (NYSE:JFR) has declined 4.92% since April 6, 2017 and is downtrending. It has underperformed by 16.47% the S&P500.

Cardiovascular Systems Inc (CSII) investors sentiment increased to 1.02 in 2017 Q4. It’s up 0.23, from 0.79 in 2017Q3. The ratio is more positive, as 59 investment managers opened new or increased equity positions, while 58 sold and reduced stakes in Cardiovascular Systems Inc. The investment managers in our database now have: 26.16 million shares, up from 24.82 million shares in 2017Q3. Also, the number of investment managers holding Cardiovascular Systems Inc in top ten equity positions was flat from 0 to 0 for the same number . Sold All: 17 Reduced: 41 Increased: 45 New Position: 14.

Cardiovascular Systems, Inc., a medical technology company, develops, makes, and markets devices to treat vascular diseases in the United States. The company has market cap of $770.67 million. The firm offers peripheral arterial disease products, including Diamondback 360 Peripheral Orbital Atherectomy System , Diamondback 360 60cm Peripheral OAS, Diamondback 360 4 French 1.25 Peripheral OAS, Diamondback 360 1.50 Peripheral OAS, Diamondback 360 2.00 Peripheral OAS, and Stealth 360 Peripheral OAS, which are catheter platforms for treating a range of plaque types in leg arteries above and below the knee, including calcified plaque, as well as address various limitations associated with surgical, catheter, and pharmacological treatment alternatives. It currently has negative earnings. It also provides Diamondback 360 Coronary OAS, an atherectomy device for the treatment of calcified coronary arteries.

Analysts await Cardiovascular Systems, Inc. (NASDAQ:CSII) to report earnings on May, 2. They expect $-0.02 EPS, down 166.67% or $0.05 from last year’s $0.03 per share. After $-0.01 actual EPS reported by Cardiovascular Systems, Inc. for the previous quarter, Wall Street now forecasts 100.00% negative EPS growth.

The stock increased 1.89% or $0.43 during the last trading session, reaching $23.2. About 164,670 shares traded. Cardiovascular Systems, Inc. (CSII) has declined 21.67% since April 6, 2017 and is downtrending. It has underperformed by 33.22% the S&P500.

First Light Asset Management Llc holds 2.88% of its portfolio in Cardiovascular Systems, Inc. for 444,004 shares. Perkins Capital Management Inc owns 61,000 shares or 1.39% of their US portfolio. Moreover, Ironwood Investment Management Llc has 0.98% invested in the company for 57,887 shares. The Wisconsin-based Cortina Asset Management Llc has invested 0.81% in the stock. Redwood Investments Llc, a Massachusetts-based fund reported 474,506 shares.

Investors sentiment decreased to 1.19 in Q4 2017. Its down 0.26, from 1.45 in 2017Q3. It is negative, as 4 investors sold Nuveen Floating Rate Income Fund shares while 23 reduced holdings. 13 funds opened positions while 19 raised stakes. 11.11 million shares or 10.08% less from 12.36 million shares in 2017Q3 were reported. Sii Investments Wi holds 0.01% in Nuveen Floating Rate Income Fund (NYSE:JFR) or 11,000 shares. Fifth Third Retail Bank has 2,000 shares. Lpl Ltd Liability Corp holds 0% in Nuveen Floating Rate Income Fund (NYSE:JFR) or 33,633 shares. Royal Bancshares Of Canada owns 39,574 shares. Ipg Advsr Limited Liability Co holds 0.01% or 2,607 shares. Cahill Fincl Advsrs holds 55,675 shares. Wells Fargo & Mn has invested 0% in Nuveen Floating Rate Income Fund (NYSE:JFR). Edgemoor Advsr reported 87,712 shares stake. Tiemann Investment Advsrs Ltd accumulated 34,117 shares or 0.3% of the stock. Cetera Advisor Ltd Co has invested 0.01% in Nuveen Floating Rate Income Fund (NYSE:JFR). Oppenheimer Communications invested in 0.01% or 23,578 shares. Bb&T Securities Limited Liability Corporation has 16,538 shares. Morgan Stanley holds 1.10M shares. Koshinski Asset Management Incorporated owns 48,377 shares or 0.14% of their US portfolio. State Bank Of Ny Mellon Corporation holds 0% or 12,419 shares in its portfolio.

Cardiovascular Systems, Inc. (NASDAQ:CSII) Institutional Positions Chart